Immediate Impact
3 from Science/Nature 69 standout
Citing Papers
Crohn's disease
2024 Standout
Navigating the complexities of drug development for inflammatory bowel disease
2024 Standout
Works of Adrian Goldiș being referenced
Clinical remission in patients with moderate-to-severe Crohn's disease treated with filgotinib (the FITZROY study): results from a phase 2, double-blind, randomised, placebo-controlled trial
2016 Standout
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Adrian Goldiș | 448 | 344 | 181 | 35 | 737 | |
| Aysel Ülker | 352 | 235 | 234 | 41 | 631 | |
| Wan‐Ju Lee | 362 | 273 | 130 | 44 | 692 | |
| Roni Weisshof | 532 | 361 | 183 | 30 | 763 | |
| Edyta Szymańska | 532 | 356 | 220 | 55 | 777 | |
| Wee Chian Lim | 444 | 337 | 219 | 28 | 797 | |
| Siro Bagnoli | 378 | 306 | 188 | 36 | 763 | |
| Abbi R. Saniabadi | 550 | 365 | 186 | 30 | 834 | |
| Jesse Siffledeen | 490 | 428 | 160 | 27 | 776 | |
| Fukiko Komaki | 339 | 320 | 220 | 33 | 757 | |
| Richard A. Lirio | 611 | 488 | 237 | 30 | 795 |
All Works
Login with ORCID to disown or claim papers
Loading papers...